134 related articles for article (PubMed ID: 17034124)
1. Determination of the binding mode of thienopyrimidinedione antagonists to the human gonadotropin releasing hormone receptor using structure-activity relationships, site-directed mutagenesis, and homology modeling.
Betz SF; Lio FM; Gao Y; Reinhart GJ; Guo Z; Mesleh MF; Zhu YF; Struthers RS
J Med Chem; 2006 Oct; 49(21):6170-6. PubMed ID: 17034124
[TBL] [Abstract][Full Text] [Related]
2. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor.
Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS
J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
[TBL] [Abstract][Full Text] [Related]
4. Allosteric and orthosteric binding modes of two nonpeptide human gonadotropin-releasing hormone receptor antagonists.
Sullivan SK; Brown MS; Gao Y; Loweth CJ; Lio FM; Crowe PD; Struthers RS; Betz SF
Biochemistry; 2006 Dec; 45(51):15327-37. PubMed ID: 17176055
[TBL] [Abstract][Full Text] [Related]
5. Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor.
Martín-Martínez M; Marty A; Jourdan M; Escrieut C; Archer E; González-Muñiz R; García-López MT; Maigret B; Herranz R; Fourmy D
J Med Chem; 2005 Jul; 48(15):4842-50. PubMed ID: 16033264
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
[TBL] [Abstract][Full Text] [Related]
7. Identification of Phe313 of the gonadotropin-releasing hormone (GnRH) receptor as a site critical for the binding of nonpeptide GnRH antagonists.
Cui J; Smith RG; Mount GR; Lo JL; Yu J; Walsh TF; Singh SB; DeVita RJ; Goulet MT; Schaeffer JM; Cheng K
Mol Endocrinol; 2000 May; 14(5):671-81. PubMed ID: 10809231
[TBL] [Abstract][Full Text] [Related]
8. Pro7.33(303) of the human GnRH receptor regulates selective binding of mammalian GnRH.
Fromme BJ; Katz AA; Millar RP; Flanagan CA
Mol Cell Endocrinol; 2004 Apr; 219(1-2):47-59. PubMed ID: 15149726
[TBL] [Abstract][Full Text] [Related]
9. Differences in structure-function relations between nonmammalian and mammalian gonadotropin-releasing hormone receptors.
Blomenröhr M; Bogerd J; Leurs R; Schulz RW; Tensen CP; Zandbergen MA; Goos HJ
Biochem Biophys Res Commun; 1997 Sep; 238(2):517-22. PubMed ID: 9299543
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor.
Janovick JA; Goulet M; Bush E; Greer J; Wettlaufer DG; Conn PM
J Pharmacol Exp Ther; 2003 May; 305(2):608-14. PubMed ID: 12606630
[TBL] [Abstract][Full Text] [Related]
12. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY
Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044
[TBL] [Abstract][Full Text] [Related]
13. Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.
Castonguay LA; Weng Y; Adolfsen W; Di Salvo J; Kilburn R; Caldwell CG; Daugherty BL; Finke PE; Hale JJ; Lynch CL; Mills SG; MacCoss M; Springer MS; DeMartino JA
Biochemistry; 2003 Feb; 42(6):1544-50. PubMed ID: 12578367
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus.
Silver MR; Sower SA
J Mol Endocrinol; 2006 Jun; 36(3):601-10. PubMed ID: 16720727
[TBL] [Abstract][Full Text] [Related]
15. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
Macion-Dazard R; Callahan N; Xu Z; Wu N; Thibonnier M; Shoham M
J Pharmacol Exp Ther; 2006 Feb; 316(2):564-71. PubMed ID: 16234409
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of 1-arylmethyl-5-aryl-6-methyluracils as potent gonadotropin-releasing hormone receptor antagonists.
Guo Z; Zhu YF; Gross TD; Tucci FC; Gao Y; Moorjani M; Connors PJ; Rowbottom MW; Chen Y; Struthers RS; Xie Q; Saunders J; Reinhart G; Chen TK; Bonneville AL; Chen C
J Med Chem; 2004 Feb; 47(5):1259-71. PubMed ID: 14971906
[TBL] [Abstract][Full Text] [Related]
17. Trapping of a nonpeptide ligand by the extracellular domains of the gonadotropin-releasing hormone receptor results in insurmountable antagonism.
Kohout TA; Xie Q; Reijmers S; Finn KJ; Guo Z; Zhu YF; Struthers RS
Mol Pharmacol; 2007 Aug; 72(2):238-47. PubMed ID: 17409285
[TBL] [Abstract][Full Text] [Related]
18. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Li H; Anderes KL; Kraynov EA; Luthin DR; Do QQ; Hong Y; Tompkins E; Sun ET; Rajapakse R; Pathak VP; Christie LC; Feng J; Vazir H; Castillo R; Gregory ML; Castro M; Nared-Hood K; Paderes G; Anderson MB
J Med Chem; 2006 Jun; 49(11):3362-7. PubMed ID: 16722655
[TBL] [Abstract][Full Text] [Related]
20. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
